+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Remote Patient Monitoring Market By Condition, By Component: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 220 Pages
  • May 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640408
The global remote patient monitoring market was valued $1,866.00 million in 2021 and expected to reach $8,451.41 million by 2031, with a CAGR of 16.3% from 2022 to 2031.

Remote patient monitoring is a subset of telemedicine that uses digital technologies to collect medical and other types of data such as patient’s recovery rate and their prescriptive guidance records about patients outside of the healthcare context. Weight, blood pressure, blood sugar, blood oxygen levels, heart rate, and electrocardiograms are all examples of data that can be transferred to healthcare providers using a telehealth computer system and software that can be loaded on a computer, smartphone, or tablet. remote patient monitoring assists health professionals in monitoring the condition of patients from all over the world,enhancing the quality of care.

The coronavirus disease (COVID-19) pandemic is one of the major drivers propelling the remote patient monitoring industry. Healthcare providers all over the world are using remote patient monitoring services to monitor patients with moderate COVID-19 symptoms and deliver timely hospital-based care, owing to the virus's highly infectious nature. This helps hospitals free up resources to serve existing and more critical patients. Another significant driver driving remote patient monitoring market expansion is the increase in frequency of cardiovascular disorders, which coincides with the growing elderly population, which is more prone to chronic conditions. Furthermore, as healthcare infrastructure improves and wireless technology advances, as well as smartphone adoption rises, healthcare services are changing from clinic-centric to patient-centric delivery models, such as remote patient monitoring. This is driving the demand for remote patient monitoring systems all across the world. Furthermore, a number of significant players offer remote patient monitoring, which allows for real-time video connection between the patient and the healthcare professional. They're also launching new products that are expected to drive the growth of the market in the future. For example, Dexcom, Inc., a medical device company based in the U.S., recently released the G6 CGM device, which is a compact sensor that checks glucose levels and transmits the data wirelessly to a display device through a transmitter.

The remote patient monitoring market is segmented on the basis of condition, component and region. By condition, the market is fragmented into congestive heart failure, diabetes, chronic obstructive pulmonary disease, blood pressure, mental health and others. By component the market is segregated into devices and software.

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major key players that operate in the global remote patient monitoring market are Abott Laboratories, Biotronik SE Co. KG, Boston Scientific Inc., Datos Health, General Electric, Honey Well International, Johnson & Johnson, Koninklijike Philips N.V., Medtronic, and Nihon Kohden.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the remote patient monitoring market analysis from 2021 to 2031 to identify the prevailing remote patient monitoring market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the remote patient monitoring market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global remote patient monitoring market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Condition

  • Congestive Heart Failure (CHF)
  • Diabetes
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Blood Pressure
  • Mental Health
  • Others

By Component

  • Devices
  • Software

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Aerotel Medical Systems (1988) Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • General Electric Company
  • Nihon Kohden Corporation
  • Medtronic Plc
  • Masimo Corporation
  • Abbott Laboratories
  • Johnson and Johnson
  • Omron Corporation
Frequently Asked Questions about the Global Remote Patient Monitoring Market

What is the estimated value of the Global Remote Patient Monitoring Market?

The Global Remote Patient Monitoring Market was estimated to be valued at $1866 million in 2021.

What is the growth rate of the Global Remote Patient Monitoring Market?

The growth rate of the Global Remote Patient Monitoring Market is 16.3%, with an estimated value of $8451.41 million by 2031.

What is the forecasted size of the Global Remote Patient Monitoring Market?

The Global Remote Patient Monitoring Market is estimated to be worth $8451.41 million by 2031.

Who are the key companies in the Global Remote Patient Monitoring Market?

Key companies in the Global Remote Patient Monitoring Market include Aerotel Medical Systems (1988) Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, General Electric Company, Nihon Kohden Corporation, Medtronic Plc, Masimo Corporation, Abbott Laboratories and Omron Corporation.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: REMOTE PATIENT MONITORING MARKET, BY CONDITION
4.1 Overview
4.1.1 Market size and forecast
4.2 Congestive Heart Failure (CHF)
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Diabetes
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Chronic Obstructive Pulmonary Disease (COPD)
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Blood Pressure
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Mental Health
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Others
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: REMOTE PATIENT MONITORING MARKET, BY COMPONENT
5.1 Overview
5.1.1 Market size and forecast
5.2 Devices
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Software
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: REMOTE PATIENT MONITORING MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Condition
6.2.3 North America Market size and forecast, by Component
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Condition
6.2.4.1.2 Market size and forecast, by Component
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Condition
6.2.4.2.2 Market size and forecast, by Component
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Condition
6.2.4.3.2 Market size and forecast, by Component
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Condition
6.3.3 Europe Market size and forecast, by Component
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Condition
6.3.4.1.2 Market size and forecast, by Component
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Condition
6.3.4.2.2 Market size and forecast, by Component
6.3.4.3 U.K.
6.3.4.3.1 Market size and forecast, by Condition
6.3.4.3.2 Market size and forecast, by Component
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Condition
6.3.4.4.2 Market size and forecast, by Component
6.3.4.5 Spain
6.3.4.5.1 Market size and forecast, by Condition
6.3.4.5.2 Market size and forecast, by Component
6.3.4.6 Rest of Europe
6.3.4.6.1 Market size and forecast, by Condition
6.3.4.6.2 Market size and forecast, by Component
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Condition
6.4.3 Asia-Pacific Market size and forecast, by Component
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Market size and forecast, by Condition
6.4.4.1.2 Market size and forecast, by Component
6.4.4.2 China
6.4.4.2.1 Market size and forecast, by Condition
6.4.4.2.2 Market size and forecast, by Component
6.4.4.3 Australia
6.4.4.3.1 Market size and forecast, by Condition
6.4.4.3.2 Market size and forecast, by Component
6.4.4.4 India
6.4.4.4.1 Market size and forecast, by Condition
6.4.4.4.2 Market size and forecast, by Component
6.4.4.5 South Korea
6.4.4.5.1 Market size and forecast, by Condition
6.4.4.5.2 Market size and forecast, by Component
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Market size and forecast, by Condition
6.4.4.6.2 Market size and forecast, by Component
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Condition
6.5.3 LAMEA Market size and forecast, by Component
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Condition
6.5.4.1.2 Market size and forecast, by Component
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Condition
6.5.4.2.2 Market size and forecast, by Component
6.5.4.3 South Africa
6.5.4.3.1 Market size and forecast, by Condition
6.5.4.3.2 Market size and forecast, by Component
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Market size and forecast, by Condition
6.5.4.4.2 Market size and forecast, by Component
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Aerotel Medical Systems (1988) Ltd.
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Biotronik SE & Co. KG
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Boston Scientific Corporation
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 General Electric Company
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Nihon Kohden Corporation
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Medtronic Plc
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Masimo Corporation
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Abbott Laboratories
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Johnson and Johnson
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Omron Corporation
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 2. Remote Patient Monitoring Market Revenue, for Congestive Heart Failure (Chf), by Region, 2021-2031, ($Million)
Table 3. Remote Patient Monitoring Market for Congestive Heart Failure (Chf) by Country, 2021-2031, ($Million)
Table 4. Remote Patient Monitoring Market Revenue, for Diabetes, by Region, 2021-2031, ($Million)
Table 5. Remote Patient Monitoring Market for Diabetes by Country, 2021-2031, ($Million)
Table 6. Remote Patient Monitoring Market Revenue, for Chronic Obstructive Pulmonary Disease (Copd), by Region, 2021-2031, ($Million)
Table 7. Remote Patient Monitoring Market for Chronic Obstructive Pulmonary Disease (Copd) by Country, 2021-2031, ($Million)
Table 8. Remote Patient Monitoring Market Revenue, for Blood Pressure, by Region, 2021-2031, ($Million)
Table 9. Remote Patient Monitoring Market for Blood Pressure by Country, 2021-2031, ($Million)
Table 10. Remote Patient Monitoring Market Revenue, for Mental Health, by Region, 2021-2031, ($Million)
Table 11. Remote Patient Monitoring Market for Mental Health by Country, 2021-2031, ($Million)
Table 12. Remote Patient Monitoring Market Revenue, for Others, by Region, 2021-2031, ($Million)
Table 13. Remote Patient Monitoring Market for Others by Country, 2021-2031, ($Million)
Table 14. Global Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 15. Remote Patient Monitoring Market Revenue, for Devices, by Region, 2021-2031, ($Million)
Table 16. Remote Patient Monitoring Market for Devices by Country, 2021-2031, ($Million)
Table 17. Remote Patient Monitoring Market Revenue, for Software, by Region, 2021-2031, ($Million)
Table 18. Remote Patient Monitoring Market for Software by Country, 2021-2031, ($Million)
Table 19. Remote Patient Monitoring Market, by Region, 2021-2031, ($Million)
Table 20. North America Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 21. North America Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 22. North America Remote Patient Monitoring Market, by Country, 2021-2031, ($Million)
Table 23. U.S. Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 24. U.S. Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 25. Canada Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 26. Canada Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 27. Mexico Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 28. Mexico Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 29. Europe Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 30. Europe Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 31. Europe Remote Patient Monitoring Market, by Country, 2021-2031, ($Million)
Table 32. Germany Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 33. Germany Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 34. France Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 35. France Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 36. U.K. Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 37. U.K. Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 38. Italy Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 39. Italy Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 40. Spain Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 41. Spain Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 42. Rest of Europe Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 43. Rest of Europe Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 44. Asia-Pacific Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 45. Asia-Pacific Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 46. Asia-Pacific Remote Patient Monitoring Market, by Country, 2021-2031, ($Million)
Table 47. Japan Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 48. Japan Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 49. China Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 50. China Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 51. Australia Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 52. Australia Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 53. India Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 54. India Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 55. South Korea Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 56. South Korea Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 57. Rest of Asia-Pacific Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 58. Rest of Asia-Pacific Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 59. LAMEA Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 60. LAMEA Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 61. LAMEA Remote Patient Monitoring Market, by Country, 2021-2031, ($Million)
Table 62. Brazil Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 63. Brazil Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 64. Saudi Arabia Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 65. Saudi Arabia Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 66. South Africa Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 67. South Africa Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 68. Rest of LAMEA Remote Patient Monitoring Market, by Condition, 2021-2031, ($Million)
Table 69. Rest of LAMEA Remote Patient Monitoring Market, by Component, 2021-2031, ($Million)
Table 70. Aerotel Medical Systems (1988) Ltd.: Company Snapshot
Table 71. Aerotel Medical Systems (1988) Ltd.: Operating Segments
Table 72. Aerotel Medical Systems (1988) Ltd.: Product Portfolio
Table 73. Aerotel Medical Systems (1988) Ltd.: Net Sales
Table 74. Aerotel Medical Systems (1988) Ltd.: Key Stratergies
Table 75. Biotronik Se & Co. Kg: Company Snapshot
Table 76. Biotronik Se & Co. Kg: Operating Segments
Table 77. Biotronik Se & Co. Kg: Product Portfolio
Table 78. Biotronik Se & Co. Kg: Net Sales
Table 79. Biotronik Se & Co. Kg: Key Stratergies
Table 80. Boston Scientific Corporation: Company Snapshot
Table 81. Boston Scientific Corporation: Operating Segments
Table 82. Boston Scientific Corporation: Product Portfolio
Table 83. Boston Scientific Corporation: Net Sales
Table 84. Boston Scientific Corporation: Key Stratergies
Table 85. General Electric Company: Company Snapshot
Table 86. General Electric Company: Operating Segments
Table 87. General Electric Company: Product Portfolio
Table 88. General Electric Company: Net Sales
Table 89. General Electric Company: Key Stratergies
Table 90. Nihon Kohden Corporation: Company Snapshot
Table 91. Nihon Kohden Corporation: Operating Segments
Table 92. Nihon Kohden Corporation: Product Portfolio
Table 93. Nihon Kohden Corporation: Net Sales
Table 94. Nihon Kohden Corporation: Key Stratergies
Table 95. Medtronic plc: Company Snapshot
Table 96. Medtronic plc: Operating Segments
Table 97. Medtronic plc: Product Portfolio
Table 98. Medtronic plc: Net Sales
Table 99. Medtronic plc: Key Stratergies
Table 100. Masimo Corporation: Company Snapshot
Table 101. Masimo Corporation: Operating Segments
Table 102. Masimo Corporation: Product Portfolio
Table 103. Masimo Corporation: Net Sales
Table 104. Masimo Corporation: Key Stratergies
Table 105. Abbott Laboratories: Company Snapshot
Table 106. Abbott Laboratories: Operating Segments
Table 107. Abbott Laboratories: Product Portfolio
Table 108. Abbott Laboratories: Net Sales
Table 109. Abbott Laboratories: Key Stratergies
Table 110. Johnson and Johnson: Company Snapshot
Table 111. Johnson and Johnson: Operating Segments
Table 112. Johnson and Johnson: Product Portfolio
Table 113. Johnson and Johnson: Net Sales
Table 114. Johnson and Johnson: Key Stratergies
Table 115. Omron Corporation: Company Snapshot
Table 116. Omron Corporation: Operating Segments
Table 117. Omron Corporation: Product Portfolio
Table 118. Omron Corporation: Net Sales
Table 119. Omron Corporation: Key Stratergies
LIST OF FIGURES
Figure 1. Remote Patient Monitoring Market Segmentation
Figure 2. Remote Patient Monitoring Market, 2021-2031
Figure 3. Remote Patient Monitoring Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Remote Patient Monitoring Market:Drivers, Restraints and Opportunities
Figure 12. Remote Patient Monitoring Market, by Condition, 2021 (%)
Figure 13. Comparative Share Analysis of Congestive Heart Failure (Chf) Remote Patient Monitoring Market, 2021-2031 (%)
Figure 14. Comparative Share Analysis of Diabetes Remote Patient Monitoring Market, 2021-2031 (%)
Figure 15. Comparative Share Analysis of Chronic Obstructive Pulmonary Disease (Copd) Remote Patient Monitoring Market, 2021-2031 (%)
Figure 16. Comparative Share Analysis of Blood Pressure Remote Patient Monitoring Market, 2021-2031 (%)
Figure 17. Comparative Share Analysis of Mental Health Remote Patient Monitoring Market, 2021-2031 (%)
Figure 18. Comparative Share Analysis of Others Remote Patient Monitoring Market, 2021-2031 (%)
Figure 19. Remote Patient Monitoring Market, by Component, 2021 (%)
Figure 20. Comparative Share Analysis of Devices Remote Patient Monitoring Market, 2021-2031 (%)
Figure 21. Comparative Share Analysis of Software Remote Patient Monitoring Market, 2021-2031 (%)
Figure 22. Remote Patient Monitoring Market by Region, 2021
Figure 23. U.S. Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 24. Canada Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 25. Mexico Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 26. Germany Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 27. France Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 28. U.K. Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 29. Italy Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 30. Spain Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 31. Rest of Europe Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 32. Japan Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 33. China Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 34. Australia Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 35. India Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 36. South Korea Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 37. Rest of Asia-Pacific Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 38. Brazil Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 39. Saudi Arabia Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 40. South Africa Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 41. Rest of LAMEA Remote Patient Monitoring Market, 2021-2031 ($Million)
Figure 42. Top Winning Strategies, by Year
Figure 43. Top Winning Strategies, by Development
Figure 44. Top Winning Strategies, by Company
Figure 45. Product Mapping of Top 10 Players
Figure 46. Competitive Dashboard
Figure 47. Competitive Heatmap of Top 10 Key Players
Figure 48. Aerotel Medical Systems (1988) Ltd. Net Sales, ($Million)
Figure 49. Biotronik SE & Co. KG.: Net Sales, ($Million)
Figure 50. Boston Scientific Corporation.: Net Sales, ($Million)
Figure 51. General Electric Company.: Net Sales, ($Million)
Figure 52. Nihon Kohden Corporation.: Net Sales, ($Million)
Figure 53. Medtronic PLC.: Net Sales, ($Million)
Figure 54. Masimo Corporation.: Net Sales, ($Million)
Figure 55. Abbott Laboratories.: Net Sales, ($Million)
Figure 56. Johnson and Johnson.: Net Sales, ($Million)
Figure 57. Omron Corporation.: Net Sales, ($Million)

Executive Summary

According to this report titled, 'Remote Patient Monitoring Market,' the remote patient monitoring market was valued at $1.9 billion in 2021, and is estimated to reach $8.5 billion by 2031, growing at a CAGR of 16.3% from 2022 to 2031.

Remote patient monitoring devices check patients' body temperature, respiration rate, heart rate, and blood pressure without invasive treatments. Day-to-day monitoring equipment, such as glucometers for diabetic patients and heart or blood pressure monitors for cardiac patients, are examples of remote patient monitoring technologies. Information can be delivered to a physician's office through a software application installed on the patient's internet-capable computer, smartphone, or tablet using telehealth communication lines. These multi-parameter remote monitoring systems, such as sleep and activity monitors, are utilized not only by medical experts but also by the general public who are concerned about their health. Companies are expected to invest in remote patient monitoring devices to alter their ready-to-work practices during the pandemic as most COVID-19 patients are asymptomatic. COVID-19 has laid a solid platform for doctors and patients to successfully employ remote patient monitoring.

The World Health Organization (WHO) on January 30, 2021 declared COVID-19 as a pandemic and general wellbeing crisis of international concern. COVID-19 has impacted around 210 countries across the globe,owing to the COVID-19 pandemic. State-run administrations across the globe declared inescapable lockdowns as well as social distancing measures to forestall breakdown of the healthcare structure. States have additionally given constraints and preventions on undertakings and elective surgeries. These obstructions continue to influence the growth of different industries and the enhanced response toward these regulations affects the industry. The distribution, production, and store network have been impacted, due to lockdowns across the globe.

Similarly, the remote patient monitoring market had a positive impact during the pandemic, owing to social distancing norms and least availability of hospital beds prompted for maximum adaptation of home-based patient care system. Hence, overall, the pandemic had a positive impact on remote monitoring market.

The major factors that drive the growth of global remote patient monitoring market trends are increase in lifestyle changes, surge in number of chronic disease, and rise in demand for home-based monitoring systems. Ambulatory healthcare that allows patients to utilize a mobile medical device to perform a routine test and send the results to a healthcare expert in real time is known as remote patient monitoring. Globally, the growing chronic disease population, combined with an geriatric population and increase in demand for home-based monitoring devices, is propelling the market growth. In addition, there is increase in tendency of adaption towards patient welfare is to opt for treatment from homes to save money on hospital fees. Increase in usage of remote patient monitoring devices across the globe is a result of hospitals' rise in financial burden from a large number of inpatients. Furthermore, people prefer home healthcare, owing to the privacy, cost-effectiveness, and convenience, all of which contribute to market growth.) In recent years, rise in healthcare costs, particularly in hospital settings, have moved attention to alternate treatment options, such as home healthcare. As a result, in upcoming years demand for effective home-use equipment, including thermometers, pulse oximeters, weight scales, ECG monitors, event monitors, EEG recorders, and fetal monitors is increasing. As a result, rise inn emphasis on a healthy lifestyle, growth in concerns about continuous monitoring of patients' health parameters, and surge in trend of self-monitoring and preventive medicine propel the growth of the market.

The remote patient monitoring market share is segmented on the basis of condition, component and region. By condition, the market is fragmented into congestive heart failure, diabetes, chronic obstructive pulmonary disease, blood pressure, mental health and others. The congestive heart failure segment dominated the market in 2021 with a revenue of $916.75 million. Growth of the segment is attributed to rising burden of chronic diseases such as heart diseases due to lifestyle changes and the rising geriatric population. By component the market is segregated into devices and software. The device segment dominated the market in 2021 with a revenue of $1,453.63 million. The growth of the segment can be attributed to surge in incidences of chronic diseases, such as diabetes and COPD and the growing demand for home-based monitoring devices are responsible for the high growth rate. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Region wise, in remote patient monitoring industry, North America dominated the global market in 2021 with a revenue of $746.40 million, which is attributed to increase in the geriatric population and cancer.

KEY FINDINGS OF STUDY

  • The study provides an in-depth analysis of the remote patient monitoring market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers remote patient monitoring market analysis from 2021 to 2031, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global remote patient monitoring market growth.

Companies Mentioned

  • Aerotel Medical Systems (1988) Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • General Electric Company
  • Nihon Kohden Corporation
  • Medtronic Plc
  • Masimo Corporation
  • Abbott Laboratories
  • Johnson and Johnson
  • Omron Corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...